A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
NCT01571557
·
clinicaltrials.gov ↗
COMPLETED
Status
573
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Edema
Retinal Vein Occlusion
Interventions
DRUG:
dexamethasone 700 ug intravitreal implant
Sponsor
Allergan